Your strategic queries, competitive analysis, and regulatory intelligence are sovereign assets. Cortex treats them that way — isolated, encrypted, and under your complete control.
No shared databases. No co-mingled processing. No cross-client exposure. Your intelligence environment is yours alone — because the moment your strategic data touches shared infrastructure, it stops being strategic.
Board-level intelligence shouldn't reach the entire organization. Role-based access ensures each person sees exactly what they need to act on — nothing more, nothing less. Access is controlled, auditable, and revocable.
When intelligence enters your decision chain without provenance, your organization inherits the risk of whatever that intelligence got wrong. Every Cortex output includes full source attribution, reasoning path, and confidence scoring.
Every access event, every document ingestion, every output delivery is logged and auditable. When regulators or compliance teams ask who saw what and when, you have the answer — instantly.
Nothing enters the system without organizational approval. Every document, every data source, every integration goes through structured governance — because ungoverned intelligence is just noise with liability attached.
Encrypted at rest. Encrypted in transit. Industry-standard protocols at every layer. Because if your intelligence infrastructure can be intercepted, it isn't intelligence — it's a liability.
Biopharma organizations operate under FDA oversight, institutional data governance, and security audit regimes that punish failure severely. Cortex was designed from the ground up for this reality — not retrofitted from a consumer product that was never meant to hold strategic intelligence.
A data breach in biopharma doesn't just cost money. It costs regulatory standing, investor confidence, and competitive positioning that took years to build. Cortex treats security as the foundation everything else is built on — not a checkbox added after the fact.